Panel Discussion with Ophthalmologist team from China

2015年在11月11日
中国的眼科专家,也是推进中国角膜捐赠、角膜移植的先行者,姚晓明医生及其团队来西雅图访问(姚晓明医生简历详见http://baike.baidu.com/subview/1385442/10315176.htm)。Seattle Chinese Biomedical Association (SCBA) 和WAHPA一起,在11月11日上午,与姚晓明医生及其随行人员进行座谈交流。本次活动除了从国内来的姚小明医生等一行眼科专家来介绍他们在国内从事的眼角膜捐赠和移植事业,还有来自西雅图的有从事角膜研究的专家、眼科医生 沈彤(Dr Teung Shen)和病理医生林惠国教授等医生参加交流,同时华盛顿大学的许多基础科学家和教授们也一起出席,其中生物结构系教授兼系主任 Dr. Rachel Wong为大家展示她实验室视网膜研究最新进展,非常精彩。
座谈会期间,各个参与者从各个不同的专业角度阐述了国内外临床和基础科研的动态和今后发展方向,并探讨了国内外科学家和医生在科研,医疗和公益事业上找寻相关课题题,并为将来的合作寻求机会。本次活动成功举办,彰显了SCBA作为西雅图医学和科研领域的强强组织,在科研和临床,国内和国际交流方面的桥梁纽带作用。同时也是一个推动我们SCBA举办更多学术交流活动的良好契机。

SCBA Board

Up coming SCBA annual meeting, September 13th 2015

Featured Keynote speaker:
Dr Xiaodong Wang (王晓东 院士)
Director, NIBS, Beijing, Member of the National Academy of Sciences USA

Dear SCBA Members and Friends:

Our SCBA All-Members Annual Meeting will take place on Sunday, September 13th, 2015 from 8:30 AM to 2:00 PM at the UW Genome Sciences Building Room Foege-060.

This year, we have lined up world class speakers from international and local academic and non-profit institutions. The keynote speaker will be Dr. Xiaodong Wang, Director, National Institute of Biological Sciences, Beijing, Member of the USA National Academy of Sciences, and member of the Chinese Academy of Sciences. Dr. Wang will talk about “Scientific innovation in China.” In addition, we will have Dr. Nathan Price, associate director of the Institute for Systems Biology and co-founder of Arivale, who will talk about “Scientific wellness and the pioneer-100 project.” Dr. Liangcai Gu, Assistant Professor, UW Biochemistry Department, who will talk about “Molecular interaction sequencing technologies for protein analysis and engineering.” And Dr. Qiang Tian, Scientific Director of the P4 Medicine Institute and Associate Professor, UW School of Medicine, who will talk about “P4Mi disease-wellness initiatives.”

Registration fee is $15 ($10 for students), which covers the annual membership. Free lunch will be provided for SCBA members.

Please RSVP to office@scbahome.org no later than Sunday, September 6, 2015 so that we can prepare logistics accordingly. Lunch may not be guaranteed without preregistration, so please RSVP today by replying this email!

Best Regards,

SCBA office

Website: http://www.scbahome.org/

Special Lecture: Novel Cellular Factors Inhibiting HIV and Other Viral Infections

Speaker: Shan-Lu Liu, MD, Ph.D.
演讲人:刘善虑 博士
When: February 28, 2015 (Saturday), from 7:00 pm
时间:2015 年2 月28 日(星期六)晚上七时起
Where: Health Science Building, Room K-450
地点:华盛顿大学医学院K-450 会议室
Note: Free parking during seminar time in UW campus

About speaker: Dr. Shan-Lu Liu is currently an associate professor in the Department of Molecular Microbiology and Immunology, and an investigator of Bond Life Sciences Center, University of Missouri. He is also an adjunct professor of the Department of Microbiology and Immunology, McGill University. He received his medical training in China and his Ph.D. degree from the Department of Pathology at the University of Washington in 2003. He was named as Canada Research Chair in Virology and Gene Therapy at McGill University during 2005-2010. His current research is focused on membrane fusion and cellular entry of enveloped RNA viruses, as well as innate immunity to viral infections. The model viruses that his lab has been studying include HIV, influenza A virus, HCV, and Ebola virus. He will speak on two novel families of cellular factors, i.e., IFITMs (IFN-induced transmembrane proteins) and TIMs (T-cell immunoglobulin and mucin domain proteins), which broadly inhibit viral infections.

Best Regards,
SCBA office

The New SCBA Board members were elected

December 8th, 2014.

Current Board Members and devision:

President: 林惠国 (Edward LIN)

Secretary-General (秘书长):邵保海 (Baohai SHAO)

Deputy Secretary (副秘书长):李沫 (Mo LI)

Honorary Members (荣誉理事): 于军 (Jun YU), 黄解于 (Jieyu HUANG)

Board Members (理事): 田强 (Qiang TIAN), 郑宁 (Ning ZHENG), 许文清 (Wenqing XU), 杨展涛 (Zhangtao YANG),

叶晓岚 (Xiaolan YE), 方向东 (Xiangdong FANG), 陈迎章 (Yingzhang CHEN). 刘燕 (Yan LIU), 王昊 (Hao WANG),

王文斌 (Wenbin WANG),许文峰 (Wenfeng XU)

2014 SCBA All-Member Meeting

November 1st, 2014 SCBA All-Member Meeting was held from 1:30pm to 6:00pm, at the UW Genome Sciences Building (Foege-060).

In this annual meeting, the world class speakers from local academic and non-profit institutions, as well as biotech industry were invited. The keynote speaker, Dr. William A. Catterall, Professor and Chair of the Department of Pharmacology at University of Washington, and a member of the US National Academy of Science gave an updated view on “Structural and functional studies of the voltage-gated sodium channels”. In addition, we had “2014 Gateway Cancer Researcher of the Year” Dr. Edward H. Lin from UW/FHCRC to share with us his award winning ADAPT trial for advanced colorectal cancer (CRC); Dr. Yiwu He, Associate Director of Translational Sciences from Bill and Melinda Gates Foundation, to discuss vision and strategy for fighting global infectious diseases including Ebola; and Dr. Che-Leung Law, a Senior Director of Seattle Genetics, to talk about industrial perspective of drug development.
The 2014 SCBA All-Member Annual Meeting was launched with a great success. Thanks to all participants!
During the meeting, we will also elect new members to join the SCBA Board.

October 2014

Dear SCBA Members and Friends:

As promised, our highly anticipated SCBA All-Member Meeting will take place on November 1st, Saturday, from 1:30pm to 6:00pm, at the UW Genome Sciences Building (Foege-060).

This year, we have lined up world class speakers from local academic and non-profit institutions, as well as biotech industry. The keynote speaker will be Dr. William A. Catterall, Professor and Chair of the Department of Pharmacology at University of Washington, and a member of the US National Academy of Science and the Royal Society of London, UK. Dr. Catterall will speak on structural and functional studies of the voltage-gated sodium channels. In addition, we will have “2014 Gateway Cancer Researcher of the Year” Dr. Edward H. Lin from UW/FHCRC to share with us his award winning ADAPT trial for advanced colorectal cancer (CRC); Dr. Yiwu He, Associate Director of Translational Sciences from Bill and Melinda Gates Foundation, to discuss vision and strategy for fighting global infectious diseases including Ebola; and Dr. Che-Leung Law, a Senior Director of Seattle Genetics, to talk about industrial perspective of drug development.

During the meeting, we will also elect new members to join the SCBA Board.

We highly encourage you all to come join us for this exciting event, discussing cutting-edge sciences, sharing the significant accomplishments of our members, and socializing.

The registration fee is $15, which covers the annual membership and a dinner.

Please RSVP to office@scbahome.org so that we can prepare logistics accordingly.

If you have any further questions, feel free to contact Dr. Ning Zheng (nzheng@u.washington.edu) and/or Dr. Qiang Tian (Qiang.Tian@systemsbiology.org).

We look forward to seeing you all on Nov. 1st.

Best regards,

SCBA Board

May 2014

Dear members,

The Seattle Chinese Biomedical Association (SCBA) Board is delighted to announce three upcoming events that will take place in the rest of 2014. On June 7th, we will host a panel discussion about career development in industry, featuring four active members from local pharma/biotech companies. On August 9th, our annual summer BBQ picnic will be held at the Matthew Beach, where new and old members can get together, relax, and socialize. On Novemer 1st, we will celebrate
our organization’s 20th anniversary with the long-due annual full member meeting, highlighted by a prominent keynote speaker, a review of our activities, and election of the new President,Secretary-General, and Board members.

Please mark your calendar and look out for announcement of the details of these exciting activities. We are looking forward to seeing you on all three events.

Sincerely yours,

ZHENG Ning, PhD, President
TIAN Qiang, MD PhD, Secretary-General

On behalf of the SCBA Board